Heart Disease Trial, Recruiting NCT07451522 Sponsor: Primorsky Regional General Hospital #1 Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07451522
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People who are scheduled for coronary artery bypass graft (CABG) heart surgery
  • People with a body weight that falls within a healthy to moderate range (BMI between 18.5 and 35 kg/m²)
  • People who are in generally good to moderate overall health before surgery, rated as low surgical risk (ASA score below 3) (confirm with trial site)
  • People who have not taken medications before surgery that affect how pain is felt
  • People with no active infection at the time of joining
  • People who have given their written agreement to take part

Who may not be able to join:

  • People who do not meet the inclusion criteria listed above
  • People rated as high surgical risk (ASA class IV or higher), particularly those likely to need prolonged breathing machine support or who have unstable blood pressure
  • People who have a known allergy or medical reason preventing the use of the study medications tafalgin or morphine, or any related opioid medicines
  • People who are pregnant or breastfeeding
  • People with current or prolonged heavy use of alcohol, barbiturates, opioids, or benzodiazepines
  • People currently taking a type of medication called MAO inhibitors, or who stopped taking them less than 14 days ago
  • People with severe liver disease (cirrhosis, Child-Pugh class C)
  • People with serious kidney failure currently requiring dialysis or a similar kidney replacement treatment
  • People with a cancer that has not been surgically removed
  • People with a serious unexplained abdominal pain condition at the time of joining
  • People currently taking part in another clinical trial
  • People with significant suppression of brain and nervous system function from any cause, other than acute poisoning
  • People with severe chronic lung disease (COPD stage III) or asthma that is currently flaring up
  • People with a psychiatric, physical, or other condition that would prevent reliable assessment of their responses or ability to follow the trial requirements
  • People who experience serious blood pressure or circulation instability after surgery requiring high doses of heart-supporting medications or mechanical heart support (confirm with trial site for specific thresholds)
  • People who choose not to participate
  • People with any other significant medical condition or history that, in the treating doctor's judgement, makes participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Evgenii Kokarev, PhD

Phone: +79644530700

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Primorsky Regional General Hospital #1
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Visual Analogue Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov